Cas:308103-43-7 3,6-Di-O-(tert-butyldiphenylsilyl)-D-glucal manufacturer & supplier

We serve Chemical Name:3,6-Di-O-(tert-butyldiphenylsilyl)-D-glucal CAS:308103-43-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,6-Di-O-(tert-butyldiphenylsilyl)-D-glucal

Chemical Name:3,6-Di-O-(tert-butyldiphenylsilyl)-D-glucal
CAS.NO:308103-43-7
Synonyms:MFCD01321280;D-Glucose, 3,6-bis-O-[(1,1-dimethylethyl)diphenylsilyl]-;3,6-Bis-O-[(2-methyl-2-propanyl)(diphenyl)silyl]-D-glucose
Molecular Formula:C38H48O6Si2
Molecular Weight:656.955
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:702.3±60.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.588
PSA:
Exact Mass:656.298950
LogP:13.05

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like MFCD01321280 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,6-Bis-O-[(2-methyl-2-propanyl)(diphenyl)silyl]-D-glucose physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD01321280 Use and application,3,6-Bis-O-[(2-methyl-2-propanyl)(diphenyl)silyl]-D-glucose technical grade,usp/ep/jp grade.


Related News: ��No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,�� said Kristen Devito, Global Director, Catalent Clinical Supply Services. 3,6-Di-O-(tert-butyldiphenylsilyl)-D-glucal manufacturer ��No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,�� said Kristen Devito, Global Director, Catalent Clinical Supply Services. 3,6-Di-O-(tert-butyldiphenylsilyl)-D-glucal supplier It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. 3,6-Di-O-(tert-butyldiphenylsilyl)-D-glucal vendor Health officials said it remained unclear where he had developed the disease. 3,6-Di-O-(tert-butyldiphenylsilyl)-D-glucal factory From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.